Crab Shell Ingredient for Blood Sugar Control
Orisett is backed by two human trials.
NutraGenesis LLC (Brattleboro, VT) is ready to market a crab shell ingredient for blood sugar control. Called Orisett, the water-soluble powder contains chitosan bioactives and is backed by animal and human studies.
In a “gold standard” trial, Orisett improved insulin sensitivity and lowered glucose spikes over long-term durations and immediately after eating periods. The company says one of the ingredient’s mechanisms of action is its ability to block alpha-glucosidase, an enzyme that allows the body to digest sugar. Several studies also confirm the safety of this ingredient, says the company.
Nutragenesis is supplying the crab shell ingredient through a partnership with Kunpoong Bio Company Ltd. of South Korea. Orisett can be formulated in product formats such as capsules, tablets, gummies, stick packs, and snack bars.
Sirio Pharma launches line of ready-to-market organic gummies and softgels called PureOrganix
August 26th 2024The new line is made up of three gummies and one softgel that are formulated to meet stringent EU-Organic certification criteria, and target women’s health, metabolic health, and heart health.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
